Drug Target Review

OCTOBER 30, 2024

As we continue to evolve our drug characterisation processes at Verseon, we see the extensive use of assembloids as essential enabling technology for the future of all drug development. Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. 2016;530(7589):177-83.

Treatment 105

Treatment Disease Clinical Trials Molecular Biology 105

Drug Target Review

MARCH 15, 2024

Emerging novel approaches to enable the workflow The development of biotherapeutic molecules has evolved significantly over the past two decades. Technology advancements have enabled a significantly more streamlined and efficient cell line development process. References Mistry RK, Kelsall E, Sou SN, et al.

Engineering 105

Engineering Molecular Biology Protein Expression Medical Schools 105

Drug Target Review

SEPTEMBER 22, 2023

5 Organoids are recognised as New Alternative Methods (NAMs) in drug development. This recognition was codified by the United States Food and Drug Administration (FDA) in 2022 with the signing of the FDA Modernisation Act 2.0 This can aid in the development of safer, more effective therapeutic strategies. Front Genet.

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

Drug Target Review

FEBRUARY 19, 2024

I always found science fascinating, but I really fell in love with it in high school when I was introduced to biochemistry and molecular biology. Biochemistry and molecular biology fascinated me in school. I am proud to have contributed to the advancements in monoclonal antibody discovery and development.

Molecular Biology 110

Molecular Biology Science Protein Expression Production 110

Codon

FEBRUARY 13, 2024

Locus has products in development targeting four common sources of bacterial infections: E. The resulting data are fed into an analytical engine that runs millions of simulations. Because frankly, do you know of anything else that can work against multiple drug-resistant bacteria? aeruginosa, S. aureus, and K. pneumoniae.

Therapies 128

Therapies Virus DNA Clinical Trials 128

Elrig

APRIL 29, 2024

She is involved in the research and development of cellular assays across multiple research areas for live-cell analysis applications, including AI-based image analysis tools. Driven by an interest in drug discovery Millie joined AstraZeneca after completion of her PhD at the end of 2020.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

The Pharma Data

JANUARY 4, 2021

Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Barber also serves on Kiromic’s Scientific Advisory Board.

Therapies 40

Therapies Molecular Biology Immune Response Science 40